NBTY on NYSE
This article was originally published in The Tan Sheet
Executive Summary
Bohemia, N.Y.-based firm to trade common stock shares on New York Stock Exchange, NBTY announces Sept. 2. The company will remain on Nasdaq through close of business Sept. 18, begin trading on NYSE Sept. 19 under symbol "NTY." NBTY's issue closed Tuesday at 27.04, up 2.2%. The stock is almost back to its 52-week high of 27.40 on Aug. 22...
You may also be interested in...
Dr Reddy’s Knocked Back On Rituximab In US
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.
Sandoz And Samsung Celebrate Stelara Rival’s EU Approval
Sandoz and Samsung Bioepis have received final European Commission approval for their partnered Pyzchiva biosimilar rival to Stelara. But with European competition on ustekinumab due to kick off in just a matter of months, further applicants are also waiting in the wings.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.